The PI Oversight Gap: What Regulators Expect in Rare Trials—and How Sponsors Can Protect Their Programs

The PI Oversight Gap: What Regulators Expect in Rare Trials—and How Sponsors Can Protect Their Programs

We meet with Dr. Han Phan, Founder and CEO of Rare Disease Research, Head of Research, and Principal Investigator on over 100 rare-disease clinical trials in the past eight years to discuss PI oversight given a changing clinical research market.